167 related articles for article (PubMed ID: 18239958)
1. Association of increased active PTH(1-84) fraction with decreased GFR and serum Ca in predialysis CRF patients: modulation by serum 25-OH-D.
Kurajoh M; Inaba M; Yamada S; Imanishi Y; Tsuchida T; Ishimura E; Nishizawa Y
Osteoporos Int; 2008 May; 19(5):709-16. PubMed ID: 18239958
[TBL] [Abstract][Full Text] [Related]
2. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H
Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
[TBL] [Abstract][Full Text] [Related]
4. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y
Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
[TBL] [Abstract][Full Text] [Related]
5. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
Olmos JM; Hernández JL; García-Velasco P; Martínez J; Llorca J; González-Macías J
Osteoporos Int; 2016 Jan; 27(1):105-13. PubMed ID: 26134682
[TBL] [Abstract][Full Text] [Related]
6. Serum 25-Hydroxyvitamin D Insufficiency in Search of a Bone Disease.
Shah S; Chiang C; Sikaris K; Lu Z; Bui M; Zebaze R; Seeman E
J Clin Endocrinol Metab; 2017 Jul; 102(7):2321-2328. PubMed ID: 28379394
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study.
Carter JL; O'Riordan SE; Eaglestone GL; Delaney MP; Lamb EJ
Nephrol Dial Transplant; 2008 Nov; 23(11):3554-65. PubMed ID: 18544628
[TBL] [Abstract][Full Text] [Related]
8. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
9. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
Boudville NC; Hodsman AB
Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777
[TBL] [Abstract][Full Text] [Related]
10. Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.
Streeten EA; Rogstad AS; Flammer KM; Zarbalian K; Ryan K; Horwitz M; Holick MF; Shelton J
Endocr Pract; 2013; 19(1):91-9. PubMed ID: 23186957
[TBL] [Abstract][Full Text] [Related]
11. Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study.
Osima M; Borgen TT; Lukic M; Grimnes G; Joakimsen RM; Eriksen EF; Bjørnerem Å
Osteoporos Int; 2018 Feb; 29(2):421-431. PubMed ID: 29134242
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis.
Lee DY; Jee JH; Cho YY; Jang JY; Yu TY; Kim TH; Hong YJ; Hong WJ; Jin SM; Hur KY; Kim JH; Kim SW; Chung JH; Lee MK; Min YK
Osteoporos Int; 2017 Apr; 28(4):1377-1384. PubMed ID: 28188454
[TBL] [Abstract][Full Text] [Related]
13. Combined Effects of Vitamin D Status, Renal Function and Age on Serum Parathyroid Hormone Levels.
Niculescu DA; Deacu LG; Caragheorgheopol A; Popescu N; Ghemigian A; Procopiuc C; Rosca R; Poiana C
Front Endocrinol (Lausanne); 2021; 12():657991. PubMed ID: 33995282
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
[TBL] [Abstract][Full Text] [Related]
16. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.
Kates DM; Sherrard DJ; Andress DL
Am J Kidney Dis; 1997 Dec; 30(6):809-13. PubMed ID: 9398125
[TBL] [Abstract][Full Text] [Related]
17. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.
Al-Aly Z; Qazi RA; González EA; Zeringue A; Martin KJ
Am J Kidney Dis; 2007 Jul; 50(1):59-68. PubMed ID: 17591525
[TBL] [Abstract][Full Text] [Related]
18. Role of parathyroid hormone in bone fragility of postmenopausal women with vitamin D insufficiency.
Yamauchi M; Kaji H; Nawata K; Takaoka S; Yamaguchi T; Sugimoto T
Calcif Tissue Int; 2011 May; 88(5):362-9. PubMed ID: 21287159
[TBL] [Abstract][Full Text] [Related]
19. Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients.
Gannagé-Yared MH; Farès C; Ibrahim T; Rahal ZA; Elias M; Chelala D
Metabolism; 2013 Oct; 62(10):1416-22. PubMed ID: 23769129
[TBL] [Abstract][Full Text] [Related]
20. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
